Cachexia: Common, Deadly, With an Urgent Need for Precise Definition and New Therapies

American Journal of Cardiology

Volumn 101, Issue 11 SUPPL., 2008, Pages

  Lainscak, Mitja ^a,b   Filippatos, Gerasimos S ^c   Gheorghiade, Mihai ^d   Fonarow, Gregg C ^e   Anker, Stefan D ^a,f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b General Hospital Murska Sobota   (Slovenia)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UCLA MEDICAL CENTER   (United States)

^f NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; APPETITE STIMULANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH HORMONE; MUSCLE PROTEIN;

ANOREXIA; ARTICLE; BODY MASS; CACHEXIA; CALORIC INTAKE; CALORIE MALNUTRITION; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; ENERGY CONSUMPTION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERMETABOLISM; IMMUNE RESPONSE; INFLAMMATION; MALABSORPTION; MALNUTRITION; MORTALITY; MUSCLE ATROPHY; MUSCLE WEAKNESS; NEOPLASM; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MALNUTRITION; PROTEIN SYNTHESIS; SUPPLEMENTATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

CACHEXIA; CHRONIC DISEASE; HUMANS; TERMINOLOGY AS TOPIC;

EID: 44449112123     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.02.065     Document Type: Article

References (26)

1. Anker S.D., Steinborn W., and Strassburg S. Cardiac cachexia. Ann Med 36 (2004) 518-529
2. Filippatos G.S., Anker S.D., and Kremastinos D.T. Pathophysiology of peripheral muscle wasting in cardiac cachexia. Curr Opin Clin Nutr Metab Care 8 (2005) 249-254
3. Schols A.M. Pulmonary cachexia. Int J Cardiol 85 (2002) 101-110
4. Fearon K.C., and Moses A.G. Cancer cachexia. Int J Cardiol 85 (2002) 73-81
5. Morley J.E., Thomas D.R., and Wilson M.M. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83 (2006) 735-743
6. von Haehling S., Doehner W., and Anker S.D. Nutrition, metabolism and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 73 (2007) 298-309
7. Anker S.D., John M., Pedersen P.U., Raguso C., Cicoira M., Dardai E., Laviano A., Ponikowski P., Schols A.M., Becker H.F., Böhm M., Brunkhorst F.M., Vogelmeier C., and ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on enteral nutrition: cardiology and pulmonology. DGEM (German Society for Nutritional Medicine). Clin Nutr 25 (2006) 311-318
8. Koehler F., Doehner W., Hoernig S., Witt C., Anker S.D., and John M. Anorexia in chronic obstructive pulmonary disease-association to cachexia and hormonal derangement. Int J Cardiol 119 (2007) 83-89
9. Kalantar-Zadeh K., Abbott K.C., Kronenberg F., Anker S.D., Horwich T.B., and Fonarow G.C. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol 26 (2006) 118-133
10. Kalantar-Zadeh K., Kuwae N., Wu D.Y., Shantouf R.S., Fouque D., Anker S.D., Block G., and Kopple J.D. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83 (2006) 202-210
11. Strassburg S., Springer J., and Anker S.D. Muscle wasting in cardiac cachexia. Int J Biochem Cell Biol 37 (2005) 1938-1947
12. Anker S.D., Negassa A., Coats A.J., Afzal R., Poole-Wilson P.A., Cohn J.N., and Yusuf S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361 (2003) 1077-1083
13. Anker S.D., Ponikowski P., Varney S., Chua T.P., Clark A.L., Webb-Peploe K.M., Harrington D., Kox W.J., Poole-Wilson P.A., and Coats A.J. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
14. Fonarow G.C., Abraham W.T., Albert N.M., Stough W.G., Gheorghiade M., Greenberg B.H., O'Connor C.M., Pieper K., Sun J.L., Yancy C., Young J.B., and OPTIMIZE-HF Investigators and Hospitals. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 297 (2007) 61-70
15. Lainscak M., Keber I., and Anker S.D. Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study. Int J Cardiol 106 (2006) 319-322
16. Evans W.J. What is sarcopenia?. J Gerontol A Biol Sci Med Sci 50 Spec No (1995) 5-8
17. Springer J., von Haehling S., and Anker S.D. The need for a standardized definition for cachexia in chronic illness. Nat Clin Pract Endocrinol Metab 2 (2006) 416-417
18. Jankowska E.A., Biel B., Majda J., Szklarska A., Lopuszanska M., Medras M., Anker S.D., Banasiak W., Poole-Wilson P.A., and Ponikowski P. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 114 (2006) 1829-1837
19. Lainscak M., Doehner W., and Anker S.D. Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone?!. Eur J Heart Fail 9 (2007) 2-3
20. Springer J., Filippatos G., Akashi Y.J., and Anker S.D. Prognosis and therapy approaches of cardiac cachexia. Curr Opin Cardiol 21 (2006) 229-233
21. Kennedy L.M., Dickstein K., Anker S.D., Kristianson K., Willenheimer R., and OPTIMAAL Study Group. The prognostic importance of body mass index after complicated myocardial infarction. J Am Coll Cardiol 45 (2005) 156-158
22. Fonarow G.C., Srikanthan P., Costanzo M.R., Cintron G.B., Lopatin M., and ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153 (2007) 74-81
23. Fearon K.C., Voss A.C., Hustead D.S., and Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83 (2006) 1345-1350
24. Anker S.D., Doehner W., Rauchhaus M., Sharma R., Francis D., Knosalla C., Davos C.H., Cicoira M., Shamim W., Kemp M., et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107 (2003) 1991-1997
25. Muscaritoli M., Bossola M., Aversa Z., Bellantone R., and Rossi Fanelli F. Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer 42 (2006) 31-41
26. Filippatos G., Rauchhaus M., and Anker S.D. Decompensated heart failure and cachexia: is it time to legalize anabolics?. Int J Cardiol 111 (2006) 185-186